Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd (SHA:600721)

China flag China · Delayed Price · Currency is CNY
7.60
-0.17 (-2.19%)
Jun 15, 2026, 1:15 PM CST
Market Cap2.99B +16.6%
Revenue (ttm)358.59M -8.5%
Net Income26.61M -35.9%
EPS0.07 -36.2%
Shares Out 384.55M
PE Ratio112.21
Forward PEn/a
Dividend0.04 (0.51%)
Ex-Dividend DateMay 8, 2026
Volume9,508,849
Open7.69
Previous Close7.77
Day's Range7.59 - 7.72
52-Week Range6.92 - 12.60
Beta-0.18
AnalystsStrong Buy
Price Targetn/a
Earnings DateAug 21, 2026

About SHA:600721

Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd engages in pharmaceutical research and development, clinical trials, biomedicine, commercial properties, and other businesses. It also offers comprehensive contract research organization (CRO) solutions, including one-stop, full-process services for drug R&D, such as Phase I to IV clinical trials, bioequivalence and pharmacokinetics testing, medical science services, R&D project consulting, data management and statistical services, and third-party testing, which covers bioanalytical testing, packaging ma... [Read more]

Industry Restaurants
Founded 1959
Employees 672
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600721
Full Company Profile

Financial Performance

In 2025, SHA:600721's revenue was 388.32 million, an increase of 0.66% compared to the previous year's 385.76 million. Earnings were 40.69 million, a decrease of -1.91%.

Financial Statements